The future of early cancer detection

被引：240

作者：

Fitzgerald, Rebecca C. ^{[1
]}

Antoniou, Antonis C. ^{[2
]}

Fruk, Ljiljana ^{[3
]}

Rosenfeld, Nitzan ^{[4
]}

机构：

[1] Univ Cambridge, Canc Res UK Cambridge Ctr, Early Detect Programme, Cambridge, England

[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

[3] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England

[4] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England

来源：

NATURE MEDICINE | 2022年 / 28卷 / 04期

关键词：

OFFSET RAMAN-SPECTROSCOPY; BREAST-CANCER; PROSTATE-CANCER; ARTIFICIAL-INTELLIGENCE; OXIDE NANOPARTICLES; GOLD NANOPARTICLES; CONTRAST AGENTS; RISK; MODEL; CARE;

D O I：

10.1038/s41591-022-01746-x

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A proactive approach to detecting cancer at an early stage can make treatments more effective, with fewer side effects and improved long-term survival. However, as detection methods become increasingly sensitive, it can be difficult to distinguish inconsequential changes from lesions that will lead to life-threatening cancer. Progress relies on a detailed understanding of individualized risk, clear delineation of cancer development stages, a range of testing methods with optimal performance characteristics, and robust evaluation of the implications for individuals and society. In the future, advances in sensors, contrast agents, molecular methods, and artificial intelligence will help detect cancer-specific signals in real time. To reduce the burden of cancer on society, risk-based detection and prevention needs to be cost effective and widely accessible. Technological advances are producing exquisitely sensitive cancer detection tests. This Review discusses who should be tested, and how-and looks to the future of personalized, risk-based cancer screening.

引用

页码：666 / 677

页数：12

共 146 条

[1] Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses [J].

Abbosh, C. ;

Swanton, C. ;

Birkbak, N. J. .

ANNALS OF ONCOLOGY, 2019, 30 (03) :358-359

[2] Ultrasound molecular imaging: Moving toward clinical translation [J].

Abou-Elkacem, Lotfi ;

Bachawal, Sunitha V. ;

Willmann, Juergen K. .

EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (09) :1685-1693

[3] Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps [J].

Adeyemo, Adebowale ;

Balaconis, Mary K. ;

Darnes, Deanna R. ;

Fatumo, Segun ;

Granados Moreno, Palmira ;

Hodonsky, Chani J. ;

Inouye, Michael ;

Kanai, Masahiro ;

Kato, Kazuto ;

Knoppers, Bartha M. ;

Lewis, Anna C. F. ;

Martin, Alicia R. ;

McCarthy, Mark I. ;

Meyer, Michelle N. ;

Okada, Yukinori ;

Richards, J. Brent ;

Richter, Lucas ;

Ripatti, Samuli ;

Rotimi, Charles N. ;

Sanderson, Saskia C. ;

Sturm, Amy C. ;

Verdugo, Ricardo A. ;

Widen, Elisabeth ;

Willer, Cristen J. ;

Wojcik, Genevieve L. ;

Zhou, Alicia .

NATURE MEDICINE, 2021, 27 (11) :1876-1884

[4] Gold-Loaded Polymeric Micelles for Computed Tomography-Guided Radiation Therapy Treatment and Radiosensitization [J].

Al Zaki, Ajlan ;

Joh, Daniel ;

Cheng, Zhiliang ;

De Barros, Andre Luis Branco ;

Kao, Gary ;

Dorsey, Jay ;

Tsourkas, Andrew .

ACS NANO, 2014, 8 (01) :104-112

[5] A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies [J].

Aleshin-Guendel, Serge ;

Lange, Jane ;

Goodman, Phyllis ;

Weiss, Noel S. ;

Etzioni, Ruth .

EVALUATION & THE HEALTH PROFESSIONS, 2021, 44 (01) :42-49

[6] The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers [J].

Amos, Christopher I. ;

Dennis, Joe ;

Wang, Zhaoming ;

Byun, Jinyoung ;

Schumacher, Fredrick R. ;

Gayther, Simon A. ;

Casey, Graham ;

Hunter, David J. ;

Sellers, Thomas A. ;

Gruber, Stephen B. ;

Dunning, Alison M. ;

Michailidou, Kyriaki ;

Fachal, Laura ;

Doheny, Kimberly ;

Spurdle, Amanda B. ;

Li, Yafang ;

Xiao, Xiangjun ;

Romm, Jane ;

Pugh, Elizabeth ;

Coetzee, Gerhard A. ;

Hazelett, Dennis J. ;

Bojesen, Stig E. ;

Caga-Anan, Charlisse ;

Haiman, Christopher A. ;

Kamal, Ahsan ;

Luccarini, Craig ;

Tessier, Daniel ;

Vincent, Daniel ;

Bacot, Francois ;

Van den Berg, David J. ;

Nelson, Stefanie ;

Demetriades, Stephen ;

Goldgar, David E. ;

Couch, Fergus J. ;

Forman, Judith L. ;

Giles, Graham G. ;

Conti, David V. ;

Bickeboeller, Heike ;

Risch, Angela ;

Waldenberger, Melanie ;

Brueske-Hohlfeld, Irene ;

Hicks, Belynda D. ;

Ling, Hua ;

McGuffog, Lesley ;

Lee, Andrew ;

Kuchenbaecker, Karoline ;

Soucy, Penny ;

Manz, Judith ;

Cunningham, Julie M. ;

Butterbach, Katja .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (01) :126-135

[7] 2020 list of human papillomavirus assays suitable for primary cervical cancer screening [J].

Arbyn, Marc ;

Simon, Marie ;

Peeters, Eliana ;

Xu, Lan ;

Meijer, Chris J. L. M. ;

Berkhof, Johannes ;

Cuschieri, Kate ;

Bonde, Jesper ;

Vanlencak, Anja Ostrbenk ;

Zhao, Fang-Hui ;

Rezhake, Remila ;

Gultekin, Murat ;

Dillner, Joakim ;

de Sanjose, Silvia ;

Canfell, Karen ;

Hillemanns, Peter ;

Almonte, Maribel ;

Wentzensen, Nicolas ;

Poljak, Mario .

CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) :1083-1095

[8] End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography [J].

Ardila, Diego ;

Kiraly, Atilla P. ;

Bharadwaj, Sujeeth ;

Choi, Bokyung ;

Reicher, Joshua J. ;

Peng, Lily ;

Tse, Daniel ;

Etemadi, Mozziyar ;

Ye, Wenxing ;

Corrado, Greg ;

Naidich, David P. ;

Shetty, Shravya .

NATURE MEDICINE, 2019, 25 (06) :954-+

[9] Imaging cancer cells with nanostructures: Prospects of nanotechnology driven non-invasive cancer diagnosis [J].

Augustine, Robin ;

Al Mamun, Abdulla ;

Hasan, Anwarul ;

Salam, Shaheen Abdul ;

Chandrasekaran, Ramya ;

Ahmed, Rashid ;

Thakor, Avnesh S. .

ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2021, 294

[10] iCOGS collection provides a collaborative model FOREWORD [J].

Bahcall, Orli G. .

NATURE GENETICS, 2013, 45 (04) :343-343

← 1 2 3 4 5 6 7 8 9 10 →